Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07487532Not yet recruiting
Randomised, open-label trial in Atrial fibrillation (AFib) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Recurrence of Atrial Arrhythmia After Catheter Ablation at 12 months. Planned start Apr 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07487532.